Bladder cancer and N-methyl-N-nitrosourea. II. Sub-cellular changes associated with a single noncarcinogenic dose of MNU.
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects; D005856:Germ-Free Life; D006470:Hemorrhage / Q000139:chemically induced; D006965:Hyperplasia / Q000139:chemically induced; D050356:Lipid Metabolism; D008297:Male; D008697:Methane / Q000494:pharmacology; D008928:Mitochondria / Q000187:drug effects; D009336:Necrosis / Q000139:chemically induced / Q000473:pathology; D009607:Nitrosourea Compounds / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013194:Staining and Labeling; D013997:Time Factors; D001743:Urinary Bladder / Q000166:cytology / Q000187:drug effects* / Q000473:pathology
D002273:Carcinogens; D009607:Nitrosourea Compounds; D003520:Cyclophosphamide; D008697:Methane